Metoprolol, 1-isopropylamino-3-[4-(2-methoxy-ethyl)-phenoxy]-2-propanol, is a b1--selective aryloxy propanolamine used in the treatment of cardiovascular disorders such as hypertension, arrhythmia and heart failure (1). The drug is a lipophilic adrenoreceptor antagonist (b-blocker) with a short half-life.
In the present work we developed a reverse phase liquid chromatography and tandem mass spectrometric method which is more sensitive (LOQ of 1 ng mL -1 ) than the methods reported in the literature using less plasma sample volume (100 mL). The liquid-liquid extraction method was used for extraction of analyte and internal standard, which is time saving. The method was validated by evaluating parameters such as the linearity of chromatographic response, precision, accuracy.
EXPERIMENTAL

Chemicals
Metoprolol succinate obtained from Degussa (India), nevirapine from Cipla, (India), ethyl acetate (AR grade) from Qualigens (India), ammonium acetate (AR grade) from Merck (India), acetonitrile and water (HPLC grade) from Merck (India) were used in this analysis. K 3 HEDTA (Sigma Aldrich, India) was used as anti-coagulant.
Instrumentation and LC-MS/MS conditions
The HPLC system consisted of an Agilent Technologies 1100 series system equipped with a binary pump, vacuum degasser, column oven and an auto sampler (Agilent Technologies Inc, USA). Mass spectrometric detection was performed using an API 3200 (triple quadrupole) instrument from Applied Bio Systems (MDS SCIEX, Canada) with an APCI interface. The data acquisition and control system was created using the Analyst 1.4.2 software from Applied Bio Systems. The main working parameters of the mass spectrometer are summarized in Table I . Nitrogen was produced using an on-site nitrogen generator from PEAK Scientific, UK. A C18 analytical column (Purospher Star, 4.6´150 mm, 5 mm) (Merck) was used. All chromatography experiments were carried out in iso- 
Preparation of standards and quality control samples
Stock solutions of metoprolol (1 mg mL -1 ) and internal standard (IS) nevirapine (1 mg mL -1 ) were separately prepared in 5-mL volumetric flasks with acetonitrile. The internal standard working solution (1 mg mL -1 ) was prepared by diluting its stock solution with water/acetonitrile (1:1). The working standard solution of metoprolol (50 mL) was added to 950 mL drug free plasma to obtain metoprolol concentration levels of 1, 2, 5, 10, 25, 50, 100 and 200 ng mL -1 .
Sample preparation
The plasma sample (100 mL) was transferred into a vial and then 10 mL of internal standard (1 mg mL -1 ) working solution was added. After vortexing for 30 s, 2.5 mL of extraction solvent, ethyl acetate, was added to the sample. The samples were vortexed on a shaker for 10 min and the supernatant (organic layer) was transferred into another vial. Ethyl acetate layer was evaporated under a stream of nitrogen at 40°C. The dried residue was reconstituted with 100 mL of mobile phase and vortexed. The sample was loaded into auto-injector vials and 20 mL aliquots were injected into the chromatographic system.
Method validation
The selectivity of the method was determined by analyzing blank plasma, without addition of metoprolol and IS. Three analytical batches were used to assess the precision and accuracy of the method. Each batch contained a single set of calibration standards and six replicates of regular quality control (QC) samples at three concentrations (3, 80 and 160 ng mL -1 ). The assay precision for each QC level was determined as the relative standard deviation (RSD) of the measured concentrations and the accuracy was expressed as percentage of the mean of measured concentrations over the nominal concentration. The intra-and inter-batch precisions were required to be below 15 %, and accuracy within ± 15 %. For LLOQ, the precision required should be below 20 % and accuracy within ± 20 % (16).
RESULTS AND DISCUSSION
Method development
Optimization of tandem mass spectrometry conditions. -Direct infusion method was used for optimization of compound parameters. Methanolic solutions of metoprolol and nevirapine at a concentration of 100 ng mL -1 were used. In this mode, the parent ion, source parameters such as ion spray voltage, curtain gas and compound parameters declustering potential, focusing potential were optimized, and then the product ion was optimized using product ion scan. Product ion formation was achieved by using collision gas. MRM scan mode was used for optimization of collision energy, collision cell exit potential. Flow injection analysis method was used for optimizing the source gas and source temperature. Here, 10 mmol L -1 ammonium acetate buffer and acetonitrile solution (15:85) was used at a 1.0 mL min -1 flow rate and without column. All optimized mass spectrometry parameters are summarized in Table I .
Optimization of chromatographic conditions. -The chromatographic conditions were optimized through several trials to achieve good resolution and symmetric peaks of analyte and IS as well as a short run time. The mobile phase pH 5 was found to be necessary for good sensitivity and peak shape. Optimization of extraction. -Four organic solvents, diethyl ether, hexane, ethyl acetate and dichloromethane were used in the extraction process. Ethyl acetate was found to be optimal; it can produce a clean chromatogram for a blank plasma sample and yield the highest analyte recovery from the plasma.
Method validation
The selectivity of the method was examined by analyzing (n = 6) blank human plasma extracts. As shown in Fig. 1a , there was no significant interference in the blank plasma at analyte retention time. toprolol at the LLOQ level (1 ng mL -1 ). Excellent sensitivity was observed for a 20 mL injection volume.
The eight-point calibration curve was linear over the concentration range 1-200 ng mL -1 metoprolol. The best linear fit and least-squares residuals for the calibration curve were achieved with a 1/x weighing factor, giving the mean linear regression equation y = 0.0007x + 0.0050 where y is the peak area ratio of the metoprolol to the IS and x is the metoprolol concentration (ng mL -1 ). The mean correlation coefficient of the weighted calibration curve generated during the validation was 0.9995 (± 0.0003); Table II summarizes the calibration data.
The LLOQ was defined as the lowest concentration in the standard curve that can be measured with acceptable accuracy and precision and was found to be 1 ng mL -1 in human plasma. The mean peak area for the analyte peak at LLOQ (1 ng mL -1 ) was~10--fold greater than the mean peak area for the blank human plasma samples at the analyte retention time. The imprecision and accuracy at LLOQ level were 9.2 and 90.2 %. For the within-batch experiments, the repeatability RSD and accuracy ranged from 0.9 to 8.8 % and accuracy from 89.9 to 105.8 % as shown in Table III .
Recovery of the metoprolol from the extraction procedure was examined by comparing the detector response obtained from the processed (extracted) sample and the detector response obtained for direct injection of standard solution. Recovery experiment was performed at three concentration levels (low, medium and high) with six replicates. The mean recovery for metoprolol at three different concentrations was 78.0 %. The recovery of IS was 77.6 % at the concentration used in the assay (100 ng mL -1 ). The recovery of analyte and IS was consistent.
The analytical performance of the proposed method for the determination of metoprolol in human plasma was compared with HPLC methods reported in the literature and the values are presented in Table IV . These values indicate that the present method has several advantages over the reported methods in terms of the plasma volume used for extraction, total run time, recovery of metoprolol and LOQ. For example Gowda et al. (14) reported LC-MS/MS method with limit of quantitation (LOQ) of 5 ng mL -1 for metoprolol by using 250 mL of plasma for sample preparation.
In the present work we developed a reverse phase liquid chromatography and tandem mass spectrometric method which is more sensitive (LOQ of 1 ng mL -1 ) than the methods reported in the literature using less plasma sample volume (100 mL). 
CONCLUSIONS
A sensitive, accurate and precise method based on LC-MS/MS for the determination of metoprolol in human plasma with LLOQ of 1 ng mL -1 level is described. The method can be used for the determination of metoprolol in the range of 1-200 ng mL -1 in human plasma.
